Mutant Mouse Models of Vitamin D Metabolic Enzymes

Vitamin D

Volumn 1, Issue , 2005, Pages 105-116

  St Arnaud, René ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882870275     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50010-3     Document Type: Chapter

References (90)

1. McAlpine PJ, Van Cong N, Boucheix C, Pakstis AJ, Doute RC, Shows TB The 1987 Catalog of mapped genes and report of the nomenclature committee. Cytogenet Cell Genet 1987, 46:29-101.
2. Shows TB, McAlpine PJ, Boucheix C, Collins FS, Conneally PM, Frezal J, Gershowitz H, Goodfellow PN, Hall JG, et al. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet 1987, 46:11-28.
3. Okuda KI, Usui E, Ohyama Y Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. J Lipid Res 1995, 36:1641-1652.
4. Jones G, Strugnell SA, DeLuca HF Current under-standing of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
5. Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, Eggertsen G, Bjorkhem I, Leitersdorf E Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 1998, 273:14805-14812.
6. Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS Cholic acid biosynthesis: The enzymatic defect in cerebrotendinous xanthomatosis. J Clin Invest 1979, 63:38-44.
7. Cali JJ, Hsieh CL, Francke U, Russell DW Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991, 266:7779-7783.
8. Kuriyama M, Fujiyama J, Kubota R, Nakagawa M, Osame M Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 1993, 42:1497-1498.
9. 3 in vivo and in perfused rat liver. FEBS Lett 1976, 65:211-214.
10. Cali JJ, Russell DW Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis. J Biol Chem 1991, 266:7774-7778.
11. Andersson D, Davis DL, Dahlback H, Jornvall H Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 1989, 264:8222-8229.
12. Madhok TC, DeLuca HF Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydrocycholecalciferol. Evidence for the participation of cytochrome p-450. Biochem J 1979, 184:491-499.
13. Vlahcevic ZR, Jairath SK, Heuman DM, Stravitz RT, Hylemon PB, Avadhani NG, Pandak WM Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol 1996, 270:G646-G652.
14. Bhattacharyya MH, DeLuca HF The regulation of rat liver calciferol-25-hydroxylase. J Biol Chem 1973, 248:2969-2973.
15. Guo YD, Strugnell S, Back DW, Jones G Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci USA 1993, 90:8668-8672.
16. Repa JJ, Lund EG, Horton JD, Leitersdorf E, Russell DW, Dietschy JM, Turley SD Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem 2000, 275:39685-39692.
17. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW De-orphanization of cytochome, P450 2R1: A microsomal vitamin d 25-hydroxylase. J Biol Chem 2003, 278:38084-38093.
18. 3. J Biol Chem 1978, 253:842-849.
19. Gupta RP, Hollis BW, Patel SB, Bell NH CYP3A4 is a human microsomal vitamin D-25-hydroxylase. J Bone Miner Res (in press) 2003.
20. 3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 1989, 262:173-180.
21. 3 through C-24 oxidation pathway. Biochemistry 1989, 28:1763.
22. 3 receptor up-regulation in rat osteosarcoma cells. Arch Biochem Biophys 1989, 272:459-465.
23. 3 24-hydroxylase. Biochemistry 1993, 32:76-82.
24. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH Deficient mineralization of intramembranous bone in vitamin D-24-dihydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.
25. St-Arnaud R Targeted inactivation of vitamin D hydroxylases in mice. Bone 1999, 25:127-129.
26. Kovacs CS, Kronenberg HM Maternal-fetal calcium and bone metabolism during pregnancy, puerperiu, and lactation. Endocr Rev 1997, 18:832-872.
27. 3 in blood and tissues of the vitamin D-24-hydroxylase null mouse 2004, Submitted.
28. 3. J Biol Chem 1997, 272:14115-14119.
29. 3-24-hydroxylase, a multicatalytic enzyme. Biochemistry 1996, 35:8465-8472.
30. St-Arnaud R, Glorieux FH Vitamin D and bone development. Vitamin D 1997, 293-303. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
31. Zelzer E, Olsen BR The genetic basis for skeletal diseases. Nature 2003, 423:343-348.
32. Kronenberg HM Developmental regulation of the growth plate. Nature 2003, 423:332-336.
33. 3. Vitamin D 1997, 395-522. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
34. 3-responsive phenotype characteristics of growth zone chondrocytes. Endocrinology 1995, 136:402-411.
35. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997, 94:9831-9835.
36. 3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 1992, 130:2495-2504.
37. 3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res 1997, 12:598-606.
38. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 1997, 138:3864-3872.
39. Tay BK, Le AX, Gould SE, Helms JA Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J Orthop Res 1998, 16:636-642.
40. Miller WL, Portale AA Genetic causes of rickets. Curr Opin Pediatr 1999, 11:333-339.
41. St-Arnaud R, Glorieux FH Hereditary defects in vitamin D metabolism and action. Endocrinology 2000, Vol. 2:1154-1168. W.B. Saunders, Philadelphia. 4th ed. J.L. DeGroot, J.L. Jameson (Eds.).
42. 3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
43. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001, 98:7498-7503.
44. St-Arnaud R, Demay MB Vitamin D biology. Pediatric Bone: Biology & Diseases 2003, 193-216. Elsevier/Academic Press, San Diego. F.H. Glorieux, H. Juppner, J.M. Pettifor (Eds.).
45. Delvin EE, Glorieux FH, Marie PJ, Pettifor JM Vitamin D dependency: replacemen therapy with calcitriol. J Pediatr 1981, 99:26-34.
46. Rosen JF, Finberg L Vitamin D-dependent rickets: actions of parathyroid hormone and 25-hydroxycholecalciferol. Pediatri Res 1972, 6:552-562.
47. Scriver CR, Reade TM, DeLuca HF, Hamstra AJ Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med 1978, 299:976-979.
48. Mandla S, Jones G, Tenenhouse HS Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type, I. Structural implications for the vitamin D hydroxylases. J Clin Endocrinol Metab 1992, 74:814-820.
49. 3 in rat kidney but not in intestine. J Biol Chem 1992, 267:13757-13762.
50. Lian JB, Stein GS, Stein JL, van Wijnen AJ Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem Suppl 1998, 31:62-72.
51. Denhardt DT, Noda M Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 1998, 31:92-102.
52. St-Arnaud R, Dardenne O, Glorieux FH Etiologie moléculaire des rachitismes vitamino-dépendents héréditaires. Médecine/Sciences 2001, 17:1289-1296.
53. 3. Proc Natl Acad Sci USA 1981, 78:4990-4994.
54. 3. Immunology 1986, 59:479-484.
55. 3 receptors in human thymic and tonsillar lymphocytes. J Bone Miner Res 1987, 2:239-247.
56. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 2001, 98:13324-13329.
57. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997, 16:391-396.
58. Halloran BP, DeLuca HF Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr 1980, 110:1573-1580.
59. Kwiecinski GG, Petrie GI, DeLuca HF Vitamin D is necessary for reproductive functions of the male rat. J Nutr 1989, 119:741-744.
60. 3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 2003, 18:637-643.
61. 3 in vitamin D dependency. Pediatr Res 1975, 9:593-599.
62. (3)] on selected vitamin D-regulated events in the rat. Biochem Pharmacol 2000, 60:701-708.
63. Malloy PJ, Pike JW, Feldman D The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999, 20:156-188.
64. Kollenkirchen U, Fox J, Walters MR Normocalcemia without hyperparathyroidism in vitamin D-deficient rats. J Bone Miner Res 1991, 6:273-278.
65. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139:4391-4396.
66. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982-4987.
67. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). Bone 2003, 32:332-340.
68. Hewison M, O'Riordan JLH Immunomodulatory and cell differentiation effects of vitamin D. Vitamin D 1997, 447-462. Academic Press, San Diego. L. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
69. Bikle D Vitamin D and skin. Vitamin D 1997, 379-394. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
70. Jiang R, Gridley T Gene targeting: Things go better with Cre. Curr Biol 1997, 7:R321-R323.
71. Panda DK, Al Kawas S, Seldin MF, Hendy GN, Goltzman D 25-hydroxyvitamin D 1α-hydroxylase: structure of the mouse gene chromosomal assignment, and developmental expression. J Bone Miner Res 2001, 16:46-56.
72. Chen W, Thiboutot D, Zouboulis CC Cutaneous androgen metabolism: basic research and clinical perspective. J Invest Dermatol 2002, 119:992-1007.
73. Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G, Bélanger A Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000, 25:1-16.
74. 3. Stimulation of defective migration of AIDS patients. J Immunol 1990, 145:2459-2464.
75. 3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987, 62:229-234.
76. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, Glass CK Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci USA 1995, 92:5391-5395.
77. Pillai S, Bikle DD, Elias PM Vitamin D and epidermal differentiation: Evidence for a role of endogenously produced vitamin D metabolites in keratinocyte differentiation. Skin Pharmacol 1988, 1:149-160.
78. 3. Biochemistry 1986, 25:1545-1548.
79. Pillai S, Bikle DD, Elias PM 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988, 263:5390-5395.
80. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986, 86:709-714.
81. Vinson LJ, Singer EJ, Kowbler WR, Lehman MD, Masurat T The nature of the epidermal barrier and some factors influencing skin permeability. Tox Appl Pharm 1965, 7:7-19.
82. Bikle DD, Chang S, Crumrine D, Elalieh H, Man M-Q, Choi EH, Dardenne O, Xie Z, St-Arnaud R, Feingold K, Elias PM 25-hydroxyvitamin D 1 alpha hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 2004, 122:984-992.
83. Tarutani M, Itami S, Okabe M, Ikawa M, Tezuka T, Yoshikawa K, Kinoshita T, Takeda J Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci USA 1997, 94:7400-7405.
84. Vasioukhin V, Degenstein L, Wise B, Fuchs E The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci USA 1999, 96:8551-8556.
85. 3 1α-and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner. Calcif Tissue Int 1999, 64:50-56.
86. St-Arnaud R, Dardenne O, Prud'homme J, Hacking SA, Glorieux FH Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). J Cell Biochem 2003, 88:245-251.
87. Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol 2003, 162:139-148.
88. 3 treated non-hypertrophic chondrocytes. Connect Tissue Res 1990, 24:29-39.
89. Kato Y, Shimazu A, Iwamoto M, Nakashima K, Koike T, Suzuki F, Nishii Y, Sato K Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc Natl Acad Sci USA 1990, 87:6522-6526.
90. 3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J Bone Miner Res 2002, 17:1604-1612.